Ashleigh Palmer, Director and CEO at Provention Bio, Inc. (PRVB), bought 3,750 shares at $6.66 ($25K) on 2021-11-30, disclosed to the SEC on 2021-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| PRVB | BUY | 2020-08-18 | $6K | — | Filing → |
| PRVB | BUY | 2020-08-17 | $36K | — | Filing → |
| PRVB | BUY | 2019-12-23 | $24K | — | Filing → |